RichdaleAPriorM. The sleep/wake rhythm in children with autism. Eur Child Adolesc Psychiatry1995;4:175–86.
2.
AmanMVan BourgondienMOsbornePSarphareG. Side effects associated with psychoactive medication in individuals with autism [letter]. J Autism Dev Disord1997;27:342–4.
3.
GreenWH. Child and adolescent clinical psychopharmacology. 2nd ed.Baltimore: Williams & Wilkins; 1995.
4.
McDougleCHomesJ, Bronson M, and others. Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. J Am Acad Child Adolesc Psychiatry1997;36:685–93.
5.
SchoplerEReichlerRRennerRochen B. The childhood autism rating scale (CARS) for diagnostic screening and classification of autism. New York: Irvington Publishers; 1986.
6.
FismanSSteeleM. Use of risperidone in pervasive developmental disorders: A case series. J Child Adolesc Psychopharmacol1996;6:177–90.
7.
NicolsonRAwadGSlomanL. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry1998;37:372–6.
8.
GreenhillL. The use of psychotropic medication in preschoolers: Indications, safety and efficacy. Can J Psychiatry1998;43:576–81.
9.
JensenP. Ethical and pragmatic issues in the use of psychotropic agents in young children. Can J Psychiatry1998;43:585–8.
10.
KinsbourneM. Disorders of mental development. In: MenkesJH, editor. Textbook of child neurology. Philadelphia: Lea and Febiger; 1985. p 764–801.
11.
BirdJ. Epilepsy and learning disabilities. In: RussellO, editor. Seminars in the psychiatry of learning disabilities. London: Royal College of Psychiatrists; 1997. p 223–44.
12.
StreissguthAP. Fetal alcohol syndrome. Baltimore (MD): Paul H Brookes; 1997. p 55–94.
13.
BermanRFBeareDJChurchMWAbelEL. Audiogenic seizure susceptibility and auditory brainstem responses in rats prenatally exposed to alcohol. Alcohol Clin Exp Res1992;16:490–8.
14.
LemoinePHorousseauHBorteyruJPNeuetJC. Les enfants de parents alcoholiques anomalies observées à propos de 127 cas. Quest Medical1968;25:476–82.
15.
HavlicekVChildiaevaRChemickV. EEG frequency spectrum characteristics of sleep states in infants of alcoholic mothers. Neuropadiatrie1977;8:360–73.
16.
SorbelJMorzoratiSO'ConnorSLiT-KChristianJC. Alcohol effects on the heritability of EEG spectral power. Alcohol Clin Exp Res1996;20:1523–9.
17.
StassenHHBonbenGProppingP. Genetic aspects of the EEG: An investigation into the within pair similarity of monozygotic and dizygotic twins with a new method of analysis. Electroencephalogr Clin Neurophysiol1987;66:489–501.
18.
ProppingP. Genetic control of ethanol action on the central nervous system: An EEG study in twins. Hum Genet1977;35:309–34.
19.
RichelsonE. Preclinical pharmacology of neuroleptics: Focus on new generation compounds. J Clin Psychiatry1996;57Suppl 11:4–11.
20.
RichelsonE. Synaptic effects of antidepressants. J Clin Psychophannacol1996;6(2 Suppl):1S–9S.
21.
BaldessariniRJ. Drugs and the treatment of psychiatric disorders. In: HardmanJGLimbirdLEMolinoffPBRuddonRWGilmanGoodman A, editors. Goodman & Gilman's The pharmacological basis of therapeutics. 9th ed.New York: McGraw-Hill; 1996. p 399–459.
22.
KrobothPDBonatePSmithRBSuarezE. Clonazepam (Klonopin)® and sertraline (Zoloft)® – absence of drug-interaction in a multiple-dose study. Clin Pharmacol Ther1997;61:PI153–PI153.
23.
SprouleBAOttonSVCheungSWZhongXHRomachMKSellersEM. Cyp2D6 inhibition in patients treated with sertraline. J Clin Psychopharmacol1997;17:102–6.
24.
AldermanJPreskomSHGreenblattDJHarrisonWPenenbergDAllisonJChungM. Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. J Clin Psychopharmacol1997;17:284–91.
ThorKBKatofiascMA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther1995;274:1014–24.
29.
MarcusNMSmithDSantelliRKayeW. Characterization of eating behavior in obese binge eaters. Int J Eat Disord1992;12:249–55.
30.
SpitzerRLYanovskiSZWaddenTAWingRRStunkardAJ, Devlin M, and others. Binge eating disorder: Its further validation in a multiside study. Int J Eat Disord1993;13:137–53.
31.
RosenJC. Body image assessment and treatment in controlled study of eating disorders. Int J Eat Disord1996;20:331–43.
32.
ScopinaroNGianettaEAdamiGFFriedmanDTraversoE, Marinari GM, and others. Biliopancreatic diversion for obesity at eighteen years. Surgery1996;119:261–8.
33.
GamerMGOlmstedPPolivyJ. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord1983;2:15–34.
34.
AdamiGFGandolfoPMeneghelliAScopinaroN. Binge eating in obesity: A longitudinal study following biliopancreatic diversion. Int J Eat Disord1996;20:405–13.
35.
TakharJManchandaR. Acute dystonic reaction with risperidone. Can J Psychiatry1996;41:61–2.
36.
BrodyAL. Acute dystonia induced by rapid increase in risperidone dosage. J Clin Psychopharmacol1996;16:461–2.
37.
FaulkRSGilmoreJMJensenEWPerkinsDO. Risperidone induced dystonic reaction. Am J Psychiatry1996;153:577.
38.
LeoRJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry1996;57:449–54.